209 related articles for article (PubMed ID: 11194241)
1. Potential short-term economic benefits of improved glycemic control: a managed care perspective.
Menzin J; Langley-Hawthorne C; Friedman M; Boulanger L; Cavanaugh R
Diabetes Care; 2001 Jan; 24(1):51-5. PubMed ID: 11194241
[TBL] [Abstract][Full Text] [Related]
2. Relationship between glycemic control and diabetes-related hospital costs in patients with type 1 or type 2 diabetes mellitus.
Menzin J; Korn JR; Cohen J; Lobo F; Zhang B; Friedman M; Neumann PJ
J Manag Care Pharm; 2010 May; 16(4):264-75. PubMed ID: 20433217
[TBL] [Abstract][Full Text] [Related]
3. The cost to health plans of poor glycemic control.
Gilmer TP; O'Connor PJ; Manning WG; Rush WA
Diabetes Care; 1997 Dec; 20(12):1847-53. PubMed ID: 9405905
[TBL] [Abstract][Full Text] [Related]
4. Evaluating the burden of poor glycemic control associated with therapeutic inertia in patients with type 2 diabetes in the UK.
Bain SC; Bekker Hansen B; Hunt B; Chubb B; Valentine WJ
J Med Econ; 2020 Jan; 23(1):98-105. PubMed ID: 31311364
[No Abstract] [Full Text] [Related]
5. The absence of a glycemic threshold for the development of long-term complications: the perspective of the Diabetes Control and Complications Trial.
Diabetes; 1996 Oct; 45(10):1289-98. PubMed ID: 8826962
[TBL] [Abstract][Full Text] [Related]
6. The Association Between Sustained HbA1c Control and Long-Term Complications Among Individuals with Type 2 Diabetes: A Retrospective Study.
Boye KS; Thieu VT; Lage MJ; Miller H; Paczkowski R
Adv Ther; 2022 May; 39(5):2208-2221. PubMed ID: 35316502
[TBL] [Abstract][Full Text] [Related]
7. Health and economic effects of adding nateglinide to metformin to achieve dual control of glycosylated hemoglobin and postprandial glucose levels in a model of type 2 diabetes mellitus.
Salas M; Ward A; Caro J
Clin Ther; 2002 Oct; 24(10):1690-705. PubMed ID: 12462297
[TBL] [Abstract][Full Text] [Related]
8. Effect of improved glycemic control on health care costs and utilization.
Wagner EH; Sandhu N; Newton KM; McCulloch DK; Ramsey SD; Grothaus LC
JAMA; 2001 Jan; 285(2):182-9. PubMed ID: 11176811
[TBL] [Abstract][Full Text] [Related]
9. Assessment of glycemic control using glycated hemoglobin among diabetic patients in Jimma University specialized hospital, Ethiopia.
Cheneke W; Suleman S; Yemane T; Abebe G
BMC Res Notes; 2016 Feb; 9():96. PubMed ID: 26879899
[TBL] [Abstract][Full Text] [Related]
10. Metabolic memory: Evolving concepts.
Misra A; Bloomgarden Z
J Diabetes; 2018 Mar; 10(3):186-187. PubMed ID: 29091343
[TBL] [Abstract][Full Text] [Related]
11. Usefulness of glycated hemoglobin A1c-based adjusted glycemic variables in diabetic patients presenting with acute ischemic stroke.
Yang CJ; Liao WI; Wang JC; Tsai CL; Lee JT; Peng GS; Lee CH; Hsu CW; Tsai SH
Am J Emerg Med; 2017 Sep; 35(9):1240-1246. PubMed ID: 28363620
[TBL] [Abstract][Full Text] [Related]
12. Glycemic control paradox: Poor glycemic control associated with higher one-year and eight-year risks of all-cause hospitalization but lower one-year risk of hypoglycemia in patients with type 2 diabetes.
Li TC; Kardia SL; Li CI; Chen CC; Liu CS; Yang SY; Muo CS; Peyser PA; Lin CC
Metabolism; 2015 Sep; 64(9):1013-21. PubMed ID: 26026367
[TBL] [Abstract][Full Text] [Related]
13. Health care costs in people with diabetes and their association with glycemic control and kidney function.
McBrien KA; Manns BJ; Chui B; Klarenbach SW; Rabi D; Ravani P; Hemmelgarn B; Wiebe N; Au F; Clement F
Diabetes Care; 2013 May; 36(5):1172-80. PubMed ID: 23238665
[TBL] [Abstract][Full Text] [Related]
14. The 30-year cost-effectiveness of alternative strategies to achieve excellent glycemic control in type 1 diabetes: An economic simulation informed by the results of the diabetes control and complications trial/epidemiology of diabetes interventions and complications (DCCT/EDIC).
Herman WH; Braffett BH; Kuo S; Lee JM; Brandle M; Jacobson AM; Prosser LA; Lachin JM
J Diabetes Complications; 2018 Oct; 32(10):934-939. PubMed ID: 30064713
[TBL] [Abstract][Full Text] [Related]
15. Impact of Perioperative HbA1c on Reimbursements in Diabetes Mellitus Patients Undergoing Total Hip Arthroplasty: A Nationwide Analysis.
Kurowicki J; Rosas S; Khlopas A; Newman JM; Law TY; Roche MW; Higuera CA; Mont MA
J Arthroplasty; 2018 Jul; 33(7):2038-2042. PubMed ID: 29891083
[TBL] [Abstract][Full Text] [Related]
16. What are the clinical, quality-of-life, and cost consequences of 30 years of excellent vs. poor glycemic control in type 1 diabetes?
Herman WH; Braffett BH; Kuo S; Lee JM; Brandle M; Jacobson AM; Prosser LA; Lachin JM
J Diabetes Complications; 2018 Oct; 32(10):911-915. PubMed ID: 30082172
[TBL] [Abstract][Full Text] [Related]
17. Effect of short- and long-term diabetes control on in-hospital and one year mortality rates in hospitalized patients with diabetic foot.
Feldbrin Z; Shargorodsky M; Wainstein J; Melnikov D; Zandman-Goddard G
Eur J Intern Med; 2018 May; 51():29-33. PubMed ID: 29329893
[TBL] [Abstract][Full Text] [Related]
18. Short-term intensive insulin therapy could be the preferred option for new onset Type 2 diabetes mellitus patients with HbA1c > 9.
Weng J
J Diabetes; 2017 Oct; 9(10):890-893. PubMed ID: 28661564
[TBL] [Abstract][Full Text] [Related]
19. The impact of glycemic variability on length of stay and mortality in diabetic patients admitted with community-acquired pneumonia or chronic obstructive pulmonary disease.
Ferreira L; Moniz AC; Carneiro AS; Miranda AS; Fangueiro C; Fernandes D; Silva I; Palhinhas I; Lemos J; Antunes J; Leal M; Sampaio N; Faria S
Diabetes Metab Syndr; 2019; 13(1):149-153. PubMed ID: 30641688
[TBL] [Abstract][Full Text] [Related]
20. OPEN ACCESS TO DIABETES CENTER FROM THE EMERGENCY DEPARTMENT REDUCES HOSPITALIZATIONS IN THE SUSEQUENT YEAR.
Palermo NE; Modzelewski KL; Farwell AP; Fosbroke J; Shankar KN; Alexanian SM; Baker WE; Simonson DC; McDonnell ME
Endocr Pract; 2016 Oct; 22(10):1161-1169. PubMed ID: 27732094
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
